GSK 583
Chemical Name: 6-[(1,1-Dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-4-quinolinamine
Purity: ≥98%
Biological Activity
GSK 583 is a potent RIPK2 inhibitor (IC50 values are 2 and 5 nM at rat and human kinases, respectively). Displays selectivity for RIP2K over p38α, VEGFR2 and a panel of 300 kinases. Exhibits some inhibition at BRK and Aurora A. Also displays similar binding affinity, but no detectable functional activity at RIP3. Active in vivo. Moderately orally bioavailable and cell permeable.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for GSK 583
The citations listed below are publications that use Tocris products. Selected citations for GSK 583 include:
1 Citation: Showing 1 - 1
-
Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets.
Authors: Rui Et al.
J Clin Invest 2021;131
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for GSK 583
There are currently no reviews for this product. Be the first to review GSK 583 and earn rewards!
Have you used GSK 583?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image